Immunic is trading 6.79% lower at $7.41, alongside weakness in biotech stocks; no company-specific announcement explaining the move was identified as of October 13, 2026. - The XBI was down 2.01% during the regular session, while broader market indices were nearly flat. - Recent reporting describes cautious biotech sentiment amid trial setbacks and higher interest rates.